Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Notes Payables (2020 - 2025)

Stemtech's Notes Payables history spans 6 years, with the latest figure at $2.4 million for Q3 2025.

  • For Q3 2025, Notes Payables changed N/A year-over-year to $2.4 million; the TTM value through Sep 2025 reached $2.4 million, changed N/A, while the annual FY2024 figure was $2.0 million, 354.67% up from the prior year.
  • Notes Payables for Q3 2025 was $2.4 million at Stemtech, down from $2.4 million in the prior quarter.
  • Across five years, Notes Payables topped out at $2.4 million in Q2 2025 and bottomed at $446246.0 in Q4 2022.
  • The 5-year median for Notes Payables is $1.5 million (2022), against an average of $1.4 million.
  • The largest annual shift saw Notes Payables tumbled 54.38% in 2023 before it soared 354.67% in 2024.
  • A 5-year view of Notes Payables shows it stood at $453123.0 in 2021, then fell by 1.52% to $446246.0 in 2022, then rose by 0.84% to $450000.0 in 2023, then skyrocketed by 354.67% to $2.0 million in 2024, then increased by 15.41% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Notes Payables are $2.4 million (Q3 2025), $2.4 million (Q2 2025), and $2.4 million (Q1 2025).